Long-term bilateral THA study finds no osteolysis with ceramic or HXLPE bearings in patients under 65
This randomized controlled trial followed 250 patients (500 hips) under age 65 undergoing bilateral primary total hip arthroplasty for a mean of 25.5 years (range 20-30). All patients received a cementless, metaphyseal-fitting anatomic femoral stem. Hips were randomized to receive either an alumina ceramic-on-ceramic (C-O-C) bearing or an alumina ceramic-on-highly cross-linked polyethylene (C-O-HXLPE) bearing, creating a within-patient comparison.
No hip in either group developed osteolysis over the follow-up period. The mean polyethylene penetration rate for the HXLPE liners was 0.041 ± 0.005 mm/year. Implant survival rates at mean 25.5 years were high: 96.8% (95% CI, 92 to 100) for the femoral component and 97.2% (95% CI, 92 to 100) for the acetabular component in the C-O-C group, and 97.6% (95% CI, 92 to 100) for both components in the C-O-HXLPE group. Clinical and functional scores (Harris Hip Score, WOMAC, UCLA activity score) improved significantly (P < 0.05) in both groups at final follow-up.
Regarding safety, no ceramic femoral head or acetabular liner fractures were reported. The study did not report other specific adverse event rates or discontinuation data. Key limitations include the lack of a direct statistical comparison of survival rates between the two bearing groups and the specific population of patients under 65 undergoing bilateral procedures, which may limit generalizability to older patients or unilateral cases. The RCT design and long-term follow-up provide strong within-patient evidence for bearing performance in this specific cohort.